Modulation

Modulation refers to the process by which the brain adjusts how strongly or weakly a neuron, synapse, or entire circuit responds to incoming signals — not by switching activity on or off, but by shifting its responsiveness up or down.

The chemical messengers that perform this work are called neuromodulators. Unlike fast neurotransmitters such as glutamate and GABA, which open ion channels and generate a signal within milliseconds, neuromodulators operate on slower timescales, reshaping how neurons respond to other inputs rather than carrying a direct, point-to-point message.

Serotonin, dopamine, norepinephrine, acetylcholine, and the endocannabinoids are all neuromodulators. Together they exert a continuous, background influence on mood, arousal, perception, and motivation — the terrain that most psychoactive substances act on.

How it works · its role

Most neuromodulators act through G-protein-coupled receptors (GPCRs). Rather than directly opening an ion channel, binding to a GPCR triggers an intracellular signalling cascade that can alter a neuron's excitability, adjust how readily it releases its own neurotransmitter, or change which genes it expresses. These effects unfold over seconds to minutes, not milliseconds.

The practical result is that modulation changes the gain on a circuit. A modulatory signal can make a neuron more likely to fire when it receives glutamate, or less likely — effectively turning the volume on incoming signals up or down without itself generating a direct command to fire.

Some neuromodulators also spread by volume transmission, diffusing beyond the precise synapse where they were released to influence receptors across a broader patch of tissue. This contributes to their wide, sustained effects compared to fast synaptic signalling.

Relevance to substances & effects

Most psychoactive substances produce their primary effects by acting on one or more neuromodulatory systems.

Stimulants such as amphetamines and cocaine amplify dopamine and norepinephrine modulation. Dopamine shapes reward and motivation; norepinephrine governs arousal and focus. Increasing the strength of these modulatory signals produces the elevated energy, mood, and concentration that stimulants are known for.

SSRIs and related antidepressants act on serotonin modulation, the system most tied to mood, social behaviour, and sleep. Because modulation works through slow intracellular cascades, serotonergic antidepressants typically require weeks of consistent use before their subjective effects stabilise.

Classic psychedelics such as LSD and psilocin bind directly to the serotonin 5-HT₂A receptor, which modulates circuits involved in perception and cognition. Rather than simply raising serotonin levels, they mimic a strong modulatory input in pathways that process sensory information — producing the perceptual and cognitive changes characteristic of a psychedelic experience.

Cannabis acts on the endocannabinoid system, a form of retrograde modulation: instead of signalling forward from one neuron to the next, endocannabinoids travel backward, letting a postsynaptic cell tell its presynaptic neighbour how much neurotransmitter to release. This unusual direction of influence shapes memory, pain, and appetite.

Opioids mimic endogenous opioid peptides, modulating pain pathways and reward circuits to produce pain suppression and euphoria. Understanding modulation as a mechanism helps explain why chemically diverse substances — stimulants, psychedelics, cannabis, opioids — can nonetheless fall into recognisable effect families: what they share is not a molecular shape but a modulatory target.